Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00498030 · ClinicalTrials.gov registry record
Predicting Insulin Resistance in American Indian Youth
A clinical trial, sponsored by University of Nebraska.
- Completed
- Registry status
- 202
- Enrollment target
NCT00498030: Completed study, sponsored by University of Nebraska.
NCT00498030 is a clinical trial that has completed, run by University of Nebraska. The registered enrollment target is 202 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00498030 has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- 202 participants
- Enrollment target
Study Summary
The purpose of this study is to identify risks that may contribute to increased insulin resistance which may help explain some of the increased incidence of type 2 diabetes in American Indian Youth, at the Rosebud reservation ages 5 to 18 years old. If specific positive indicators of insulin resistance are present, individuals are recruited back in one year for repeat of all measures.
Primary Outcome
This study will assess for change in insulin resistance in Native American Children over one year.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 202 participants |
| Start Date | 2005-12-05 |
| Est. Completion | 2018-03-29 |
What the finished NCT00498030 record still lists
NCT00498030 is an observational study that tracks outcomes without assigning an intervention. The registered 202 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00498030 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00498030 about?
NCT00498030 is a clinical study titled "Predicting Insulin Resistance in American Indian Youth". The purpose of this study is to identify risks that may contribute to increased insulin resistance which may help explain some of the increased incidence of type 2 diabetes in American Indian Youth, at the Rosebud reservation ages 5 to 18 years old. If specific positive indicators of insulin resista...
What is the current status of trial NCT00498030?
This trial is currently completed. The enrollment target is 202 participants. The study started on 2005-12-05. Estimated completion is 2018-03-29.
Who is sponsoring clinical trial NCT00498030?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05272254 · 202 participants · Phase 2
Povidone Iodine Efficacy Study
- NCT05701280 · 202 participants · NA
Pilot/Pivotal Study of DBS+Rehab After Stroke
- NCT05932589 · 202 participants
Neurophysiologic Biomarkers in Rett Syndrome
- NCT06014931 · 202 participants · NA
Telehealth-enhanced Patient-oriented Recovery Trajectory After Intensive Care
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI